[1]
|
S. M. Ji and Z. Tang, “Polyomavirus-Associated Neph- ropathy after Renal Allograft,” Chinese Journal of Nephrology Dialysis & Transplantation, Vol. 15, No. 6, 2006, pp. 572-578.
|
[2]
|
P. S. Randhawa and A. J. Demetris, “Nephropathy Due to Polyomavirus Type BK,” New England Journal of Medicine, Vol. 342, 2000, p. 1361.
doi:10.1056/NEJM200005043421809
|
[3]
|
S. Hussain, B. A. Bresnahan, E. P. Cohen, et al., “Rapid Kidney Allograft Failure in Patients with Polyoma Virus Nephritis with Prior Treatment with Antilymphocyte Agents,” Clinical Transplantation, Vol. 16, 2002, pp. 43- 47. doi:10.1034/j.1399-0012.2002.00075.x
|
[4]
|
H. H. Hirsch, “Polyomavirus BK Nephropathy: A (Re-) Emerging Complication in Renal Transplantation,” American Journal of Transplantation, Vol. 2, 2002, p. 25.
doi:10.1034/j.1600-6143.2002.020106.x
|
[5]
|
M. Mengel, M. Marwedel, J. Radermacher, et al., “Incidence of Polyomavirus Nephropathy in Renal Allografts: Influence of Modern Immunosuppressive Drugs,” Ne- phrology Dialysis Transplantation, Vol. 18, 2003, p. 1190. doi:10.1093/ndt/gfg072
|
[6]
|
M. S. Sachdeva, R. Nada, V. Jha, et al., “The High Incidence of BK Polyoma Virus Infection among Renal Transplant Recipients in India,” Transplantation, Vol. 77, 2004, p. 429. doi:10.1097/01.TP.0000113163.02039.30
|
[7]
|
R. John and A. M. Herzenberg, “Our Approach to a Renal Transplant Biopsy,” Journal of Clinical Pathology, Vol. 63, No. 1, 2010, pp. 26-37. doi:10.1136/jcp.2009.067983
|
[8]
|
M. Ahuja, E. P. Cohen, A. M. Dayer, et al., “Polyoma Virus Infection after Renal Transplantation. Use of Im- munostaining as a Guide to Diagnosis,” Transplantation, Vol. 71, 2001, pp. 896-899.
doi:10.1097/00007890-200104150-00013
|
[9]
|
B. Celik, R. Shapiro, A. Vats, et al., “Polyomavirus Allograft Nephropathy: Sequential Assessment of Histologic Viral Load, Tubulitis and Graft Function Following Changes in Immunosuppression,” American Journal of Transplantation, Vol. 3, No. 11, 2003, pp. 1378-1382.
doi:10.1046/j.1600-6135.2003.00238.x
|
[10]
|
L. C. Racusen, K. Solez, R. B. Colvin, et al., “The Banff 97 Working Classification of Renal Allograft Pathology,” Kidney International, Vol. 55, No. 2, 1999, pp. 713-723.
doi:10.1046/j.1523-1755.1999.00299.x
|
[11]
|
G. A. Bǒhmig, M. Exner, A. Habicht, et al., “Capillary C4d Deposition in Kidney Allografts: A Specific Marker of Alloantibody-Dependent Graft Injury,” Journal of the American Society of Nephrology, Vol. 13, 2002, pp. 1091-1099.
|
[12]
|
S. Hariharan, “BK Virus Nephritis after Renal Transplan- tation,” Kidney International, Vol. 69, 2006, pp. 655-662.
doi:10.1038/sj.ki.5000040
|
[13]
|
H. P. Chen, Z. H. Liu and L. S. Zeng, “Polyomavirus-Associated Nephropathy,” Chinese Journal of Nephrology Dialysis & Transplantation, Vol. 16, No. 4, 2007, pp. 389-393.
|
[14]
|
Y. Namba, T. Moriyama, M. Kyo, et al., “Prevalence, Characteristics, and Outcome of BK Virus Nephropathy in Japanese Renal Transplant Patients: Analysis in Proto- col and Episode Biopsies,” Clinical Transplantation, Vol. 19, 2005, pp. 97-101.
doi:10.1111/j.1399-0012.2004.00305.x
|
[15]
|
H. H. Hirsch, W. Knowles, M. Dickenmann, et al., “Prospective Study of Polyomavirus Type BK Replication and Nephropathy in Renal-Transplant Recipients,” New England Journal of Medicine, Vol. 347, 2002, pp. 488-496.
doi:10.1056/NEJMoa020439
|
[16]
|
C. B. Drachenberg, C. O. Beskow, C. B. Cangro, et al., “Human Polyoma Virus in Renal Allograft Biopsies: Morphological Findings and Correlation with Urine Cytology,” Human Pathology, Vol. 30, 1999, pp. 970-977.
doi:10.1016/S0046-8177(99)90252-6
|
[17]
|
G. A. Weinberg and A. N. Mian, “BK Virus Nephropathy and Other Polyoma Virus Infections,” The Pediatric Infectious Disease Journal, Vol. 29, 2010, pp. 257-260.
doi:10.1097/INF.0b013e3181d01c6d
|
[18]
|
D. Adhania, C. Snopkowski, R. Ding, et al., “Validation of Noninvasive Diagnosis of BK Virus Nephropathy and Identification of Prognostic Biomarkers,” Transplantation, Vol. 90, 2010, pp. 189-197.
doi:10.1097/TP.0b013e3181e2a932
|
[19]
|
J. E. Greenlee, S. H. Clawson, R. C. Pheleps and W. G. Stroop, “Distribution of K-Papovavirus in Infected Newborn Mice,” Journal of Comparative Pathology, Vol. 111, 1994, pp. 259-268. doi:10.1016/S0021-9975(05)80004-0
|
[20]
|
C. B. Drachenberg, J. C. Papadimitriou, H. H. Hirsch, et al., “Histological Patterns of Polyomavirus Nephropathy: Correlation with Graft Outcome and Viral Load,” American Journal of Transplantation, Vol. 4, 2004, pp. 2082-2092. doi:10.1046/j.1600-6143.2004.00603.x
|
[21]
|
B. H. H. Chung, Y. A. Hong, H. G. Kim, et al., “Clinical Usefulness of BK Virus Plasma Quantitative PCR to Pre- vent BK Virus Associated Nephropathy,” Transplant International A 2012 European Society for Organ Trans- plantation, Vol. 25, 2012, pp. 687-695.
|
[22]
|
V. Nickeleit, H. H. Hirsch, M. Zeiler, et al., “BK Virus Nephropathy in Renal Transplants-Tubular Necrosis, MHC-Class II Expression and Rejection in a Puzzling Game,” Nephrology Dialysis Transplantation, Vol. 15, 2000, pp. 324-332. doi:10.1093/ndt/15.3.324
|
[23]
|
S. M. Ji, L. S. Li, H. P. Chen et al., “Re-Evaluation of Soluble Interleukin-2 Receptor Used in the Diagnosis of Acute Rejection,” Chinese Journal of Nephrology Dialysis & Transplantation, Vol. 5, No. 2, 1996, pp. 17-20.
|
[24]
|
D. C. Brennan, I. Agha, D. I. Bohl, et al., “Incidence of BK with Tacrolimus versus Cyclosporine and Impact of Preemptive Immunosuppression Reduction,” American Journal of Transplantation, Vol. 5, 2005, pp. 582-594.
doi:10.1111/j.1600-6143.2005.00742.x
|
[25]
|
A. S. Weiss, J. Gralla, L. Chan, et al., “Aggressive Immunosuppression Minimization Reduces Graft Loss Fol- lowing Diagnosis of BK Virus-Associated Nephropathy: A Comparison of Two Reduction Strategies,” Clinical Journal of the American Society of Nephrology, Vol. 3, 2008, pp. 1812-1819. doi:10.2215/CJN.05691207
|
[26]
|
R. Rahamimov, S. Lustig, A. Tovar, et al., “BK Polyoma Virus Nephropathy in Kidney Transplant Recipient: The Role of New Immunosuppressive Agents,” Transplantation Proceedings, Vol. 35, 2003, pp. 604-605.
doi:10.1016/S0041-1345(03)00006-X
|
[27]
|
P. V. Kadambi, M. A. Josephson, J. Williams, et al., “Treatment of Refractory BK Virus-Associated Neph- ropathy with Cidofovir,” American Journal of Transplantation, Vol. 3, 2003, pp. 186-191.
doi:10.1034/j.1600-6143.2003.30202.x
|
[28]
|
M. A. Josephson, D. Gillen, B. Javaid, et al., “Treatment of Renal Allograft Polyoma BK Virus Infection with Leflunomide,” Transplantation, Vol. 81, 2006, pp. 704-710.
doi:10.1097/01.tp.0000181149.76113.50
|